We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CW icon
651
Curtiss-Wright
CW
$22B
$1.12M 0.01%
4,117
-434
-10% -$116K
NYT icon
652
New York Times
NYT
$11B
$1.12M 0.01%
21,775
-1,853
-8% -$87.1K
BWXT icon
653
BWX Technologies
BWXT
$14B
$1.11M 0.01%
11,724
-598
-5% -$55.5K
HOOD icon
654
Robinhood
HOOD
$93.7B
$1.11M 0.01%
48,927
+7,122
+17% +$139K
UNM icon
655
Unum
UNM
$14.7B
$1.1M 0.01%
21,579
-4,103
-16% -$212K
SNX icon
656
TD Synnex
SNX
$20.3B
$1.1M 0.01%
9,500
+1,405
+17% +$172K
EWBC icon
657
East-West Bancorp
EWBC
$17.7B
$1.09M 0.01%
14,938
-1,843
-11% -$137K
FIVE icon
658
Five Below
FIVE
$13.4B
$1.08M 0.01%
9,931
-1,682
-14% -$233K
BF.B icon
659
Brown-Forman Class B
BF.B
$12.5B
$1.08M 0.01%
24,929
-19,565
-44% -$919K
DAY
660
DELISTED
Dayforce
DAY
$1.07M 0.01%
21,659
+540
+3% +$30.9K
ERIE icon
661
Erie Indemnity
ERIE
$13.6B
$1.07M 0.01%
2,957
-289
-9% -$110K
IWV icon
662
iShares Russell 3000 ETF
IWV
$20.3B
$1.07M 0.01%
3,470
-1,804
-34% -$538K
SEIC icon
663
SEI Investments
SEIC
$13.4B
$1.06M 0.01%
16,403
-1,724
-10% -$116K
CIVI
664
DELISTED
Civitas Resources
CIVI
$1.06M 0.01%
15,294
+652
+4% +$47.2K
SOLV icon
665
Solventum
SOLV
$15.5B
$1.05M 0.01%
+19,873
New +$1.21M
TPR icon
666
Tapestry
TPR
$25B
$1.05M 0.01%
24,531
-3,230
-12% -$135K
CGNX icon
667
Cognex
CGNX
$10.2B
$1.05M 0.01%
22,383
-3,397
-13% -$149K
REXR icon
668
Rexford Industrial Realty
REXR
$8.28B
$1.04M 0.01%
23,344
-1,764
-7% -$79.4K
GNRC icon
669
Generac Holdings
GNRC
$10.8B
$1.04M 0.01%
7,869
+2,577
+49% +$356K
COHR icon
670
Coherent
COHR
$54.7B
$1.03M 0.01%
14,244
-1,472
-9% -$88.5K
AR icon
671
Antero Resources
AR
$11.8B
$1.03M 0.01%
31,421
-2,372
-7% -$77.6K
PLNT icon
672
Planet Fitness
PLNT
$4.03B
$1.02M 0.01%
13,894
-105
-0.8% -$6.81K
CHE icon
673
Chemed
CHE
$6.84B
$1.02M 0.01%
1,884
-1,083
-37% -$620K
HRB icon
674
H&R Block
HRB
$6.47B
$1.02M 0.01%
18,846
-9,396
-33% -$468K
MKTX icon
675
MarketAxess Holdings
MKTX
$5.73B
$1.02M 0.01%
5,071
-3,570
-41% -$736K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.